Parâmetros hematológicos e bioquímicos séricos de jumentos (Equus asinus) da raça Pêga

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Influência da exposição à fumaça do cigarro e ao etanol sobre as alterações da mucosa do esôfago induzidas por dieta modificada em camundongos C57BL/6

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Perfil bioquímico sérico de éguas gestantes e não gestantes das raças brasileiro de hipismo e bretão

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Fotossensibilização em ovinos associada à ingestão de Brachiaria brizantha no estado do Pará

Foram estudados dois surtos e realizado um experimento de fotossensibilização associada à ingestão por Brachiaria brizantha em ovinos mestiços de Santa Inês e Dorper, com idade variando de dois a três meses, em uma fazenda no município de Santa Luzia do Pará. Esses animais foram mantidos desde o nascimento até aproximadamente dois meses de idade, em apriscos suspensos do chão, recebendo capim-elefante roxo (Pennisetum purpureum cv. roxo), concentrado, sal mineral e água ad libitum. Após esse período foram introduzidos em um piquete de B. brizantha. Na ocasião dos surtos e do experimento a fazenda foi visitada para observação dos dados epidemiológicos, avaliação clínica dos animais, colheita de amostras de sangue para dosagem de GGT, AST, BD, BI, BT, ureia e creatinina e colheita de pastagem para pesquisa de Pithomyces chartarum e saponinas. Também foi realizada necropsia com colheita de material para estudo histológico. O surto 01 ocorreu na época de escassez de chuva, com taxa de morbidade e letalidade de 43,4% e 81,6%, respectivamente. O surto 02 aconteceu no início da época chuvosa, com taxas de morbidade e letalidade de 16,3% e 76,9%, respectivamente. Em ambos os surtos o capim encontrava-se com massa residual reduzida e senescente. Dos 50 animais do experimento, 10 receberam 200ml de fluido ruminal retirado de ovelhas mães do mesmo lote, a primeira administração foi feita um dia antes da introdução desses animais na pastagem, e mais duas subsequentes com intervalo de uma semana. Após 15 dias de pastejo, os animais começaram a apresentar inquietação, procura por sombra, edema nas orelhas, mucosas amareladas, apatia, anorexia e desprendimento da pele seguido por formação de crostas em algumas áreas do corpo. Tanto os animais dos surtos quanto do experimento apresentaram aumento nos níveis de GGT, AST, BD, BI, BT, ureia e creatinina. Os valores de ureia e GGT dos animais que receberam fluido ruminal e dos que não receberam foram semelhantes, já os valores de creatinina, AST e bilirrubinas foram menores nos animais que receberam fluido ruminal em comparação aos que não receberam. Foram determinados dois tipos de saponinas nas amostras de B. brizantha dos surtos e do experimento, a metilprotodioscina e a protodioscina. O nível de saponina no surto 01 e 02 foi 0,92% e 0,88%, respectivamente. Os níveis de saponinas no experimento variaram de 1,13% a 1,62%. A quantidade de Pithomyces chartarum, tanto nos surtos quanto no experimento, foi insignificante. Na necropsia foi verificada icterícia generalizada, fígado com consistência aumentada de coloração amarelada e com padrão lobular acentuado. Nos rins foi observada coloração amarelo-esverdeado e aumento de tamanho. As alterações histológicas ocorreram principalmente no fígado e consistiram de leve proliferação das vias biliares nos espaços porta, presença de hepatócitos binucleados, presença de macrófagos espumosos, necrose incipiente de hepatócitos isolados, colangite, presença de cristais em macrófagos e hepatócitos.

Fotossensibilização em ovinos associada à ingestão de Brachiaria brizantha no estado do Pará

Foram estudados dois surtos e realizado um experimento de fotossensibilização associada à ingestão por Brachiaria brizantha em ovinos mestiços de Santa Inês e Dorper, com idade variando de dois a três meses, em uma fazenda no município de Santa Luzia do Pará. Esses animais foram mantidos desde o nascimento até aproximadamente dois meses de idade, em apriscos suspensos do chão, recebendo capim-elefante roxo (Pennisetum purpureum) cv. roxo, concentrado, sal mineral e água ad libitum. Após esse período foram introduzidos em um piquete de B. brizantha. Na ocasião dos surtos e do experimento a fazenda foi visitada para observação dos dados epidemiológicos, avaliação clínica dos animais, colheita de amostras de sangue para dosagem de GGT, AST, BD, BI, BT, uréia e creatinina e colheita de pastagem para pesquisa de Pithomyces chartarum e saponinas. Também foi realizada necropsia com colheita de material para estudo histológico. O surto 01 ocorreu na época de escassez de chuva, com taxa de morbidade e letalidade de 43,4% e 81,6%, respectivamente. O surto 02 aconteceu no início da época chuvosa, com taxas de morbidade e letalidade de 16,3% e 76,9%, respectivamente. Em ambos os surtos o capim encontrava-se com massa residual reduzida e senescente. Dos 50 animais do experimento, 10 receberam 200 ml de fluido ruminal retirado de ovelhas mães do mesmo lote, a primeira administração foi feita um dia antes da introdução desses animais na pastagem, e mais duas subsequentes com intervalo de uma semana. Após 15 dias de pastejo, os animais começaram a apresentar inquietação, procura por sombra, edema nas orelhas, mucosas amareladas, apatia, anorexia e desprendimento da pele seguido por formação de crostas em algumas áreas do corpo. Tanto os animais dos surtos quanto do experimento apresentaram aumento nos níveis de GGT, AST, BD, BI, BT, uréia e creatinina. Os valores de uréia e GGT dos animais que receberam fluido ruminal e dos que não receberam foram semelhantes, já os valores de creatinina, AST e bilirrubinas foram menores nos animais que receberam fluido ruminal em comparação aos que não receberam. Foram determinados dois tipos de saponinas nas amostras de B. brizantha dos surtos e do experimento, a metilprotodioscina e a protodioscina. O nível de saponina no surto 01 e 02 foi 0,92% e 0,88%, respectivamente. Os níveis de saponinas no experimento variaram de 1,13% a 1,62%. A quantidade de Pithomyces chartarum, tanto nos surtos quanto no experimento, foi insignificante. Na necropsia foi verificada icterícia generalizada, fígado com consistência aumentada de coloração amarelada com padrão lobular acentuado e degeneração gordurosa. Nos rins foi observada coloração amarelo-esverdeado e aumento de tamanho. As alterações histológicas ocorreram principalmente no fígado e podem ser descritas como leve proliferação das vias biliares nos espaços porta, presença de hepatócitos binucleados, presença de macrófagos espumosos, necrose incipiente de hepatócitos isolados, colangite, presença de cristais em macrófagos e hepatócitos.

The immunogenicity of chemically derived zwitterionic polysaccharides

Bacterial capsular polysaccharides (PS) which naturally contain zwitterionic charge motifs (ZPS) possess specific immunostimulatory activity, leading to direct activation of antigen-presenting cells (APCs) through Toll-like receptor 2 (TLR2) and of T cells in co-culture systems. When administered intraperitoneally, ZPS and bacteria expressing them are involved in the induction or regulation of T-cell dependent inflammatory processes such as intra-abdominal abscess formation. Moreover it has been published that ZPSs are processed to low molecular weight carbohydrates and presented to T cells through a pathway similar to that used for protein antigens. These findings were in contrast with the paradigm according to which polysaccharides are T-independent antigens unable to be presented in association with MHC class II molecules and unable to induce a protective immune response. For this reason in glycoconjugate vaccines polysaccharides often need to be conjugated to a carrier protein to induce protection. The aim of our work was to generate vaccine candidates with antigen and adjuvant properties in one molecule by the chemical introduction of a positive charge into naturally anionic PS from group B streptococcus (GBS). The resulting zwitterionic PS (ZPS) has the ability to activate human and mouse APCs, and in mixed co-cultures of monocytes and T cells, ZPS induce MHC II-dependent T-cell proliferation and up-regulation of activation markers. TLR2 transfectants show reporter gene transcription upon incubation with ZPS and these stimulatory qualities can be blocked by anti-TLR2 mAbs or by the destruction of the zwitterionic motif. However, in vivo, ZPS used alone as vaccine antigen failed to induce protection against GBS challenge, a result which does not confirm the above mentioned postulate that ZPS are T-cell dependent Ags by virtue of their charge motif. Thus to make ZPS visible to the immune system we have conjugated ZPS with a carrier protein. ZPS-glycoconjugates induce higher T cell and Ab responses to carrier and PS, respectively, compared to control PS-glycoconjugates made with the native polysaccharide form. Moreover, protection of mothers or neonate offspring from lethal GBS challenge is better when mothers are immunized with ZPS-conjugates compared to immunization with PS-conjugates. In TLR2 knockout mice, ZPS-conjugates lose both their increased immunogenicity and protective effect after vaccination. When ZPS are co-administered as adjuvants with unconjugated tetanus toxoid (TT), they have the ability to increase the TT-specific antibody titer. In conclusion, glycoconjugates containing ZPS are potent vaccines. They target Ag to TLR2-expressing APCs and activate these APCs, leading to better T cell priming and ultimately to higher protective Ab titers. Thus, rational chemical design can generate potent novel PS-adjuvants with wide application, including glycoconjugates and co-administration with unrelated protein Ags.

New synthetic bile acid analogue agonists of FXR and TGR5 receptors: Analytical methodologies for the study of their physico-chemical properties, pharmacokinetic activity and metabolism.

This thesis reports an integrated analytical approach for the study of physicochemical and biological properties of new synthetic bile acid (BA) analogues agonists of FXR and TGR5 receptors. Structure-activity data were compared with those previous obtained using the same experimental protocols on synthetic and natural occurring BA. The new synthetic BA analogues are classified in different groups according also to their potency as a FXR and TGR5 agonists: unconjugated and steroid modified BA and side chain modified BA including taurine or glycine conjugates and pseudo-conjugates (sulphonate and sulphate analogues). In order to investigate the relationship between structure and activity the synthetic analogues where admitted to a physicochemical characterization and to a preliminary screening for their pharmacokinetic and metabolism using a bile fistula rat model. Sensitive and accurate analytical methods have been developed for the quali-quantitative analysis of BA in biological fluids and sample used for physicochemical studies. Combined High Performance Liquid Chromatography Electrospray tandem mass spectrometry with efficient chromatographic separation of all studied BA and their metabolites have been optimized and validated. Analytical strategies for the identification of the BA and their minor metabolites have been developed. Taurine and glycine conjugates were identified in MS/MS by monitoring the specific ion transitions in multiple reaction monitoring (MRM) mode while all other metabolites (sulphate, glucuronic acid, dehydroxylated, decarboxylated or oxo) were monitored in a selected-ion reaction (SIR) mode with a negative ESI interface by the following ions. Accurate and precise data where achieved regarding the main physicochemical properties including solubility, detergency, lipophilicity and albumin binding . These studies have shown that minor structural modification greatly affect the pharmacokinetics and metabolism of the new analogues in respect to the natural BA and on turn their site of action, particularly where their receptor are located in the enterohepatic circulation.

Conjugation of Toll Like Receptor 7 agonist through conjugation to immunogenic proteins. Synthesis, characterization, formulation and pre-clinical evaluation

The next generation of vaccine adjuvant are represented by a wide ranging set of molecules called Toll like agonists (TLR’s). Although many of these molecules are complex structures extracted from microorganisms, small molecule TLR agonists have also been identified. However, delivery systems have not been optimized to allow their effective delivery in conjunction with antigens. Here we describe a novel approach in which a small molecule TLR agonist has been conjugated directly to antigens to ensure effective co delivery. We describe the conjugation of a relevant protein, a recombinant protective antigen from S.pneumoniae (RrgB), which is linked to a TLR7 agonist. Following thorough characterization to ensure there was no aggregation, the conjugate was evaluated in a murine infection model. Results showed that the conjugate extended animals’ survival after lethal challenge with S.pneumoniae. Comparable results were obtained with a 10 fold lower dose than that of the native unconjugated antigen. Notably, the animals immunized with the same dose of unconjugated TLR7 agonist and antigen showed no adjuvant effect. The increased immunogenicity was likely a consequence of the co-localization of TLR7 agonist and antigen by chemical binding and is was more effective than simple co-administration. Likely, this approach can be adopted to reduce the dose of antigen required to induce protective immunity, and potentially increase the safety of a broad variety of vaccine candidates

Enantioselective determination of ondansetron and 8-hydroxyondansetron in human plasma from recovered surgery patients by liquid chromatography-tandem mass spectrometry

A liquid chromatographic-mass spectrometric assay with atmospheric pressure chemical ionization for quantification of ondansetron and its main metabolite 8-hydroxyondansetron in human plasma was presented. The enantiomeric separation was achieved on a Chiralcel OD-R column containing cellulose tris-(3,5-dimethylphenylcarbamate). The validation data were within the required limits. The assay was successfully applied to authentic plasma samples. Quantitative results from postoperative patients receiving ondansetron demonstrated a great interindividual variability in postoperative plasma drug concentrations, the metabolites were not detected in their unconjugated form. A wide variation in the S-(+)-/R-(-)-ondansetron concentration ratio between 0.14 and 7.18 is indicative for a stereoselective disposition or metabolism. In further studies CYP2D6 and CYP3A4 genotype dependent metabolism of ondansetron enantiomers as well as of co-administered drugs and clinical efficacy of the medication should be tested.

Association of gastroschisis and choledochal cyst

Two infants are described who presented in the neonatal period with a direct hyperbilirubinemia. This was initially presumed to be because of the diagnosis of gastroschisis and the prolonged use of parenteral nutrition. However, both infants were eventually found to have an associated choledochal cyst. The cases are a novel association not previously reported and should heighten the awareness that anatomical causes of a direct hyperbilirubinemia need to be ruled out in all neonates.

Efficacy pneumococcal vaccination in adults: a meta-analysis

Background: Clinical trials and meta-analyses have produced conflicting results of the efficacy of unconjugated pneumococcal polysaccharide vaccine in adults. We sought to evaluate the vaccine’s efficacy on clinical outcomes as well as the methodologic quality of the trials. Methods: We searched several databases and all bibliographies of reviews and meta-analyses for clinical trials that compared pneumococcal polysaccharide vaccine with a control. We examined rates of pneumonia and death, taking the methodologic quality of the trials into consideration. Results: We included 22 trials involving 101 507 participants: 11 trials reported on presumptive pneumococcal pneumonia, 19 on all-cause pneumonia and 12 on allcause mortality. The current 23-valent vaccine was used in 8 trials. The relative risk (RR) was 0.64 (95% confidence interval [CI] 0.43–0.96) for presumptive pneumococcal pneumonia and 0.73 (95% CI 0.56–0.94) for all-cause pneumonia. There was significant heterogeneity between the trials reporting on presumptive pneumonia (I2 = 74%, p < 0.001) and between those reporting on all-cause pneumonia (I2 = 90%, p < 0.001). The RR for all-cause mortality was 0.97 (95% CI 0.87–1.09), with moderate heterogeneity between trials (I2 = 44%, p = 0.053). Trial quality, especially regarding double blinding, explained a substantial proportion of the heterogeneity in the trials reporting on presumptive pneumonia and all-cause pneumonia. There was little evidence of vaccine protection in trials of higher methodologic quality (RR 1.20, 95% CI 0.75–1.92, for presumptive pneumonia; and 1.19, 95% CI 0.95–1.49, for allcause pneumonia in double-blind trials; p for heterogeneity > 0.05). The results for all-cause mortality in double-blind trials were similar to those in all trials combined. There was little evidence of vaccine protection among elderly patients or adults with chronic illness in analyses of all trials (RR 1.04, 95% CI 0.78–1.38, for presumptive pneumococcal pneumonia; 0.89, 95% CI 0.69–1.14, for all-cause pneumonia; and 1.00, 95% CI 0.87–1.14, for all-cause mortality). Interpretation: Pneumococcal vaccination does not appear to be effective in preventing pneumonia, even in populations for whom the vaccine is currently recommended.

Aggressive vs. conservative phototherapy for infants with extremely low birth weight.

BACKGROUND: It is unclear whether aggressive phototherapy to prevent neurotoxic effects of bilirubin benefits or harms infants with extremely low birth weight (1000 g or less). METHODS: We randomly assigned 1974 infants with extremely low birth weight at 12 to 36 hours of age to undergo either aggressive or conservative phototherapy. The primary outcome was a composite of death or neurodevelopmental impairment determined for 91% of the infants by investigators who were unaware of the treatment assignments. RESULTS: Aggressive phototherapy, as compared with conservative phototherapy, significantly reduced the mean peak serum bilirubin level (7.0 vs. 9.8 mg per deciliter [120 vs. 168 micromol per liter], P<0.01) but not the rate of the primary outcome (52% vs. 55%; relative risk, 0.94; 95% confidence interval [CI], 0.87 to 1.02; P=0.15). Aggressive phototherapy did reduce rates of neurodevelopmental impairment (26%, vs. 30% for conservative phototherapy; relative risk, 0.86; 95% CI, 0.74 to 0.99). Rates of death in the aggressive-phototherapy and conservative-phototherapy groups were 24% and 23%, respectively (relative risk, 1.05; 95% CI, 0.90 to 1.22). In preplanned subgroup analyses, the rates of death were 13% with aggressive phototherapy and 14% with conservative phototherapy for infants with a birth weight of 751 to 1000 g and 39% and 34%, respectively (relative risk, 1.13; 95% CI, 0.96 to 1.34), for infants with a birth weight of 501 to 750 g. CONCLUSIONS: Aggressive phototherapy did not significantly reduce the rate of death or neurodevelopmental impairment. The rate of neurodevelopmental impairment alone was significantly reduced with aggressive phototherapy. This reduction may be offset by an increase in mortality among infants weighing 501 to 750 g at birth. (ClinicalTrials.gov number, NCT00114543.)

Characterization and function of murine Thy-1$\sp+$ dendritic epidermal cells

The skin immune system is believed to be a crucial site of contact between immunocompetent cells and invading organisms. A novel T cell component of murine epidermis is the Thy-1$\sp+$ dendritic epidermal cell (Tdec). To assess the immunocompetence of Tdec, the ability of Tdec to induce immune responses was tested. Tdec were unable to induce positive immune responses in three models of immunocompetence. Subsequent studies were designed to test the hypothesis that Tdec are involved in the down-regulation of cell-mediated immunity against cutaneous antigens. Cultured Tdec lines were conjugated in vitro with the hapten, fluorescein isothiocyanate (FITC). The intrafootpad (ifp.) or intravenous (i.v.) injection of FTIC-conjugated Tdec induced immunologic tolerance to subsequent epicutaneous sensitization with FITC. This induction of tolerance was antigen-specific, and injection of unconjugated Tdec had no effect on the contact hypersensitivity response to FITC. Tolerance was not H-2-restricted, since it could be induced in both syngeneic and allogeneic recipients of FITC-conjugated Tdec. No suppressive activity could be detected in lymphoid organs of animals tolerized by the ifp. injection of hapten-conjugated Tdec. In contrast, suppressor T cells were present in the spleens of mice injected i.v. with hapten-conjugated Tdec. These results indicate that Ts cells are not involved in the induction of tolerance by the ifp. injection of hapten-conjugated Tdec. To investigate the mechanism by which the ifp. injection of hapten-conjugated Tdec induced tolerance to contact sensitization, the activity of these cells was measured in vitro. The addition of hapten-conjugated Tdec inhibited the proliferation of Con A-stimulated lymphocytes. In addition, FITC-conjugated Tdec abrogated the proliferation of normal lymphocytes in response to FITC-labeled stimulator cells. These studies suggest that specific T cell-mediated immunity is the target of the inhibitory effect of Tdec in vitro. In summary, these results demonstrate that while Tdec are unable to induce positive immune responses, they can produce a state of specific immunologic tolerance when injected ifp. or i.v. These results also suggest that the induction of immunologic tolerance by hapten-conjugated Tdec may occur through the inactivation or elimination of activated T lymphocytes resulting in down-regulation of cell-mediated immunity against cutaneous antigens. ^

Anemia hemolítica : desafio diagnóstico

Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2014

Kernicterus e icterícia neonatal : revisão teórica a propósito de um caso clínico

Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2014